IN191482B - - Google Patents

Info

Publication number
IN191482B
IN191482B IN454DE1999A IN191482B IN 191482 B IN191482 B IN 191482B IN 454DE1999 A IN454DE1999 A IN 454DE1999A IN 191482 B IN191482 B IN 191482B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Gour Mukherji
Manoj Kumar
Himadrisen
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN454DE1999 priority Critical patent/IN191482B/en
Priority to CNA998165883A priority patent/CN1615121A/zh
Priority to BR9917219-4A priority patent/BR9917219A/pt
Priority to PCT/IB1999/001735 priority patent/WO2000056266A2/en
Priority to AU62246/99A priority patent/AU6224699A/en
Priority to EP99949283A priority patent/EP1235556A4/en
Priority to ZA200007724A priority patent/ZA200007724B/xx
Publication of IN191482B publication Critical patent/IN191482B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN454DE1999 1999-03-19 1999-03-19 IN191482B (enExample)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN454DE1999 IN191482B (enExample) 1999-03-19 1999-03-19
CNA998165883A CN1615121A (zh) 1999-03-19 1999-10-26 掩盖味道的包衣组合物
BR9917219-4A BR9917219A (pt) 1999-03-19 1999-10-26 Composições de revestimento para mascaramento de sabor
PCT/IB1999/001735 WO2000056266A2 (en) 1999-03-19 1999-10-26 Taste masking coating compositions
AU62246/99A AU6224699A (en) 1999-03-19 1999-10-26 Taste masking coating compositions
EP99949283A EP1235556A4 (en) 1999-03-19 1999-10-26 COATINGS FOR TASTE MASKING
ZA200007724A ZA200007724B (en) 1999-03-19 2001-09-19 Taste masking coating compositions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN454DE1999 IN191482B (enExample) 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
IN191482B true IN191482B (enExample) 2003-12-06

Family

ID=11089863

Family Applications (1)

Application Number Title Priority Date Filing Date
IN454DE1999 IN191482B (enExample) 1999-03-19 1999-03-19

Country Status (7)

Country Link
EP (1) EP1235556A4 (enExample)
CN (1) CN1615121A (enExample)
AU (1) AU6224699A (enExample)
BR (1) BR9917219A (enExample)
IN (1) IN191482B (enExample)
WO (1) WO2000056266A2 (enExample)
ZA (1) ZA200007724B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191239B (enExample) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
AU2002327418A1 (en) * 2001-08-01 2003-02-17 Bristol-Myers Squibb Company Taste masking composition
AU2003211146B2 (en) 2002-02-21 2007-07-19 Valeant International (Barbados) Srl Controlled release dosage forms
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
KR100193933B1 (ko) * 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
WO1993024109A1 (en) * 1992-06-04 1993-12-09 Smithkline Beecham Corporation Palatable pharmaceutical compositions
DE19709532A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen

Also Published As

Publication number Publication date
CN1615121A (zh) 2005-05-11
AU6224699A (en) 2000-10-09
ZA200007724B (en) 2002-06-12
EP1235556A2 (en) 2002-09-04
WO2000056266A2 (en) 2000-09-28
WO2000056266A3 (en) 2002-07-04
BR9917219A (pt) 2002-04-23
EP1235556A4 (en) 2003-07-16

Similar Documents

Publication Publication Date Title
BE2018C020I2 (enExample)
BE2015C057I2 (enExample)
BE2016C007I2 (enExample)
BE2013C020I2 (enExample)
BE2013C001I2 (enExample)
BE2012C036I2 (enExample)
BE2008C046I2 (enExample)
BE1025464I2 (enExample)
JP2002513254A5 (enExample)
JP2002507835A5 (enExample)
JP2002503584A5 (enExample)
JP2001118250A5 (enExample)
JP2002527967A5 (enExample)
BE2008C047I2 (enExample)
BE2011C004I2 (enExample)
JP2002516393A5 (enExample)
JP2002531727A5 (enExample)
BRPI0001542A2 (enExample)
JP2002524148A5 (enExample)
JP2002523514A5 (enExample)
JP2002532011A5 (enExample)
JP2002507104A5 (enExample)
BRPI0012675B8 (enExample)
JP2002527992A5 (enExample)
JP2000257604A5 (enExample)